Impact of the COVID-19 health crisis on psychotropic drug use in children and adolescents in France
The results show a significant increase in the consumption of psychotropic drugs among youth. The increase in psychotropic drug use was continuous and progressive throughout the pandemic. All five classes were increased, but particularly anxiolytics and antidepressants. The COVID-19 context may have been at the origin of a deterioration in the mental health of children and adolescents, or of a heightened awareness of psychiatric care among young people.
Authors
- Jérémy Jost (ORCID: https://orcid.org/0000-0001-5543-3741)
- Nicolas Bodeau
- Bertrand Olliac (ORCID: https://orcid.org/0000-0002-7442-2586)
- Benjamin Calvet (ORCID: https://orcid.org/0000-0001-7628-0430)
- Laurence Schadler
- Jérémy Couturas
- Véronique Moysan
- Bruno Lescarret
Institutions
- Inserm (FR)
- National Health Insurance Fund (RS)
- Centre Hospitalier Esquirol de Limoges (FR)
- Institut d’Epidémiologie Neurologique et de Neurologie Tropicale (FR)
- Institut de Recherche pour le Développement (FR)
- Université de Limoges (FR)
Publication Details
- Journal
- Child and Adolescent Psychiatry and Mental Health
- Published
- 2024-09-16
- DOI
- https://doi.org/10.1186/s13034-024-00806-z
- Citations
- 7
- Primary Topic
- COVID-19 and Mental Health
- Type
- article
- Field-Weighted Citation Impact
- 4.47